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Display of E. coli alkaline phosphatase pIII or pVIII fusions on
phagemids surfaces reveals monovalent decoration with active
molecules
Abstract
Active alkaline phosphatase of Escherichia coli (PhoA, EC 3.1.3.1) was displayed via the leucine zipper
element of the Jun-Fos heterodimer on the surface of filamentous phage and the kinetic parameters
K(m) and k(cat) were determined. The phoA gene was cloned downstream of fos while jun was inserted
upstream of pIII or pVIII, alternatively, in the pJuFo phagemid vector. Both fusion genes are regulated
by independent lacZ promoters. PhoA displayed on the phagemid pIII surface exhibited a K(m) of 11.2
microM with 4-nitrophenyl phosphate as substrate, which is consistent with data published for soluble
PhoA. Based on these data we calculated the decoration of pJuFo phagemid with PhoA using the minor
and major coat proteins pIII and pVIII as fusion partners under variable inducing conditions. We found
that, even if the promoters are fully induced at a concentration of 1000 microM IPTG, the phagemids
display maximally one copy of PhoA-Fos-Jun-coat protein fusion, irrespective of whether the protein is
presented via pIII or pVIII. However, since PhoA is displayed in a native-like fashion, as deduced from
the kinetic parameters of the enzymatic reaction, the pJuFo technology provides a versatile tool for the
functional screening of complex cDNA libraries displayed on the phagemids' surface.
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Abstract: Active alkaline phosphatase of Escherichia coli (PhoA, EC 3.1.3.1) was displayed via the leucine 
zipper element of the Jun-Fos heterodimer on the surface of filamentous phage and the kinetic parameters Km 
and kcat were determined. The phoA gene was cloned downstream of fos while jun was inserted upstream of pIII 
or pVIII, alternatively, in the pJuFo phagemid vector. Both fusion genes are regulated by independent lacZ 
promoters. PhoA displayed on the phagemid pIII surface exhibited a Km of 11.2 µM with 4-nitrophenyl 
phosphate as substrate, which is consistent with data published for soluble PhoA. Based on these data we 
calculated the decoration of pJuFo phagemid with PhoA using the minor and major coat proteins pIII and pVIII 
as fusion partners under variable inducing conditions. We found that, even if the promoters are fully induced at 
a concentration of 1000 µM IPTG, the phagemids display maximally one copy of PhoA-Fos-Jun-coat protein 
fusion, irrespective of whether the protein is presented via pIII or pVIII. However, since PhoA is displayed in a 
native-like fashion, as deduced from the kinetic parameters of the enzymatic reaction, the pJuFo technology 
provides a versatile tool for the functional screening of complex cDNA libraries displayed on the phagemids' 
surface. 
 
INTRODUCTION 
Most functional proteomic approaches aim at the 
identification of interactions between naturally 
occurring proteins. Once the interactions are 
known the resulting interactome networks can 
provide information about complex molecular 
interactions and improve our understanding of 
evolutionary, metabolic, molecular and cellular 
processes [1]. Recently, enhanced modifications of 
the original yeast two-hybrid system [2] have been 
used to generate entire interaction maps of the 
yeast Saccharomyces cerevisiae [3, 4] and the 
nematode worm Caenorhabditis elegans [5]. The 
problem of relatively frequent false-positive hints 
remains a major disadvantage of this in vivo 
technology [6]. As an alternative, lambda phage 
based screening or phage surface display of cDNA 
libraries are often favoured over the two-hybrid 
system, if a library needs to be screened against an 
immobilized monoclonal or oligoclonal ligand 
because both in vitro screening systems allow 
variation of the binding conditions. 
Phage display differs from other screening systems 
because molecular libraries incorporated into the 
phage genome are expressed on the surface of 
phage particles [7]. The physical linkage between 
genotype and phenotype allows maintaining a 
phage library in the liquid phase and therefore 
efficient screening based on the power of affinity 
selection. cDNA phage display systems based on 
bacteriophages T7 [8, 9], lambda [10], and  
 
 
 
 
filamentous phage [11-15] have been recently 
reported and reviewed elsewhere [16, 17]. 
Among the filamentous phage display approaches 
the pJuFo technology, which is based on an 
indirect fusion approach to display products on the 
surface of helper phage assisted phagemid 
assemblies, has widely been used for the surface 
expression of cDNA libraries, and yielded complex 
allergen repertoires of various allergenic sources 
[18]. Furthermore, the technology provided a 
valuable tool for the identification of tumor-
associated antigens [19], self-antigens [20] or 
epitopes of polyclonal antibody sera [21]. Since the 
applications of this methodology are quite diverse, 
and yet it has not met substantial limitations, we 
investigated the efficiency of the pJuFo surface 
presentation choosing E. coli alkaline phosphatase 
(PhoA, EC 3.1.3.1) as a model system. PhoA was 
cloned adjacent to fos of the pJuFo vector and 
expressed as a Jun-Fos-pIII or Jun-Fos-pVIII 
fusion protein on the phagemids' surface (Figure 
1). Under reaction conditions in which PhoA 
exhibits Michaelis-Menten behaviour we obtained 
the kinetic parameters Km and kcat of phagemid-
displayed PhoA. Comparison of these kinetic 
parameters with those of wild-type PhoA allowed 
calculating the decoration of phagemid with 
functional PhoA fusion proteins. 
 
 
 
MATERIALS AND METHODS   
Construction of pJuFoVIII::phoA 
 
Production of phage displaying PhoA of E. coli as 
a pIII fusion protein by means of the Jun-Fos linker 
is described elsewhere [11, 37]. For the 
construction of a pVIII-display pJuFo vector, the 
DNA encoding pVIII was amplified by PCR using 
M13K07 helper phage as a template and the 
following oligonucleotides: 5'-primer pVIII: 5'-
ACG GGA TCC GGT GGC GGT GGC TCT GCT 
GAG GGT GAC-3', 3'-primer pVIII: 5'-GTG TTA 
CTA GCT AGC TTT AAT TGT ATC GGT TTA-
3'. The PCR fragment was hydrolysed with BamHI 
and NheI, gel purified and used to replace the 
BamHI-NheI fragment in pJuFo. The ligation 
mixture was used to transform E. coli XL1-Blue 
(Stratagene, La Jolla, CA, USA) electrocompetent 
cells [38] which were then spread on LB agar 
plates with 100 µg/ml ampicillin and 10 µg/ml 
tetracycline (LB/Amp+Tc). Single colonies were 
picked and grown. DNA was prepared and the final 
construct was was verified by restriction analysis 
and DNA sequencing (Microsynth, Balgach, 
Switzerland). The pJuFoVIII::phoA phagemid was 
constructed by XbaI+KpnI hydrolysis of the 
pJuFoVIII vector and ligation with correspondingly 
hydrolysed phoA DNA derived from 
pJuFoIII::phoA [11]. 
 
Preparation of PhoA-phagemids 
 
110-150 ml 2×YT medium with 100 µg/ml 
ampicillin and 10 µg/ml tetracycline 
(2×YT/Amp+Tc) were inoculated 1:50 with a 
stationary culture of E. coli XL1-Blue/pJuFo::phoA 
or XL1-Blue/pJuFoVIII::phoA and incubated at 
37°C and 250 rpm until an OD550 of ≈ 0.5 was 
reached. Then helper phage VCS-M13 (Stratagene) 
was added at a multiplicity of infection (moi) of 10 
and the culture was incubated for 30 min at 30°C, 
150 rpm. After 30 min agitation of the culture was 
raised to 300 rpm and the culture was incubated for 
additional 9.5 h at 30°C. 2 h after infection with 
helper phage, kanamycin (kan) was added to a 
concentration of 70 µg/ml. For experiments, in 
which the decoration of phage with PhoA was 
determined in dependence of the inducer 
concentration, IPTG was added 30 min after 
infection with helper phage. 
PhoA-phagemid containing supernatant was 
prepared 10 h after helper phage addition by 
centrifugation (4'500 × g, 4°C, 15 min) and PhoA-
phagemid was precipitated by addition of ¼ 
volume 25% (w/v) polyethylene glycol (MW: 
8'000), 15% (w/v) NaCl at 4°C for 20 min. After 
centrifugation (15'000 × g, 4°C, 20 min) the 
supernatant was removed and the precipitated 
phagemid was dissolved in 10 mM Tris/HCl pH 
8.0 (4 vol. % of the original supernatant volume). 
After centrifugation (15'000 × g, 4°C, 10 min) the 
cleared solution was transferred into fresh tubes 
and PhoA-phagemid was precipitated again with 
PEG/NaCl as described above, the supernatant was 
removed quantitatively and precipitated PhoA-
phagemid was dissolved in 10 mM Tris/HCl pH 
8.0 (4 vol. % of the original supernatant volume). 
After final centrifugation (15'000 × g, 4°C, 10 min) 
the PhoA-phagemid solution was transferred into 
new tubes, kept at 4°C and readily used for the 
determination of infectivity and for enzymatic 
assays. Samples immediately not used for 
experiments were stored at -20°C directly after 
preparation. 
 
Inducibility of pJuFoIII::phoA and 
pJuFoVIII::phoA 
 
To test the inducibility of the phagemid vectors by 
IPTG after addition of helper phage we prepared 
periplasmic extracts of XL1-Blue using a 
moderately modified protocol for cold osmotic 
shock [39]: portions of 25 ml were taken from a 
200 ml PhoA-phagemid producing XL1-Blue 
culture at distinct times after VCS-M13 
superinfection and centrifuged (4'500 × g, 4°C, 15 
min). The supernatant was removed completely 
and bacterial pellets washed by gentle re-
suspension in 1 ml of 2×YT followed by 
centrifugation (4'500 × g, 4°C, 15 min). After 
medium removal the bacteria were resuspended in 
1 ml 500 mM Saccharose, 100 mM Tris/HCl, 1 
mM EDTA pH 8.0 and incubated on ice for 30 min 
in the presence of 100 µg/ml hen egg white 
lysozyme (Roche, Basel, Switzerland). The 
spheroplasts were sedimented (15'000 × g, 4°C, 15 
min) and the periplasmic fractions were stored at -
20°C. 
 
Western blots 
 
Western blot analysis was used to detect wild-type 
(wt) PhoA (Sigma, St. Louis, MO, USA) or Fos-
PhoA in the periplasmic fractions as well as in the 
phagemid preparations. Therefore, samples were 
subjected to SDS-PAGE (NuPAGE™, 12% Bis-
Tris, Invitrogen™) and electrotransferred onto a 
Hybond™-P PVDF membrane (Amersham 
Pharmacia Biotech, Uppsala, Sweden). Free 
binding sites were blocked with 5% non-fat dried 
milk, 0.1 % (v/v) Tween-20 in TBS. PhoA was 
detected with horse radish peroxidase labelled 
rabbit polyclonal anti-bacterial AP mAb 7319 
(1:10'000 in blocking buffer, Abcam, Cambridge, 
United Kingdom) and visualised by 
chemiluminescence (ECL™, Amersham Pharmacia 
Biotech) substrate. 
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Figure 1.  Genetic elements of the pJuFo vector and proposed mechanism for the assembly of PhoA-
phagemids. In the present work PhoA was displayed either as pIII or pVIII fusion protein via the heterodimeric 
Jun-Fos linker on the surface of filamentous phagemid. 
 
Enzymatic assays 
 
PhoA-phagemid enzyme activity was assayed 
basically as described by McCafferty et al. [31]. 
Briefly, reactions were initiated by adding 50 µl 
PhoA-phagemid solution to 950 µl of 4-nitrophenyl 
phosphate (Fluka, Buchs, Switzerland) at a range 
of concentrations in 1.052 M Tris/HCl pH 8.0. The 
initial rates were calculated from the change of the 
absorbance at 410 nm in the first 6 s of each 
reaction at 25°C using a molar absorption 
coefficient of 16'200 M-1 cm-1 [40]. The 
concentration of PhoA-phagemid was determined 
by preparing ssDNA using phenol/chloroform/ 
isopropanol extraction, ethanol precipitation and 
measuring at 260 nm. The A260/A280 ratio of the 
ssDNA prepared this way was always higher than 
1.77. The molar absorption coefficients of the 
individual single stranded vector contructs were 
calculated with the Omiga 2.0 software (Oxford 
Molecular, Oxford, England). Purified E. coli 
PhoA was purchased from Sigma. The 
concentration was calculated by measuring the  
absorbance at 278 nm [41] using a Mr of 47'029 per 
subunit [28]. The kinetic parameters Km and kcat  
 
were derived fromnonlinear least-square fits 
according to the Michaelis-Menten model. For 
practical reasons kcat values are expressed as molar 
activities (mol. act.) and specified in mol 
substrate/mol phage (or enzyme)/min throughout 
this paper. All absorption measurements were 
performed on an Uvikon XL spectrophotometer 
(Bio-Tek Instruments, Winooski, VT, USA). 
 
Phagemid infectivity 
 
Infectivity is defined as the ratio between infective 
and total phage. Total phagemid was measured by 
preparing ssDNA as described above, infective 
phagemid was determined by infecting 
exponentially growing E. coli XL1-Blue with three 
independent dilution series of each phagemid 
preparation and plating out on LB/Amp+Tc agar. 
 
RESULTS   
Kinetic properties of PhoA displayed on the 
surface of pJuFo phagemids 
 
Display of cDNA libraries on the surface of 
filamentous phage and their screening for 
interacting proteins against immobilized targets 
still remains a challenge in proteomics. Although 
also pVI as fusion partner for cDNA products has 
been described [13, 14, 22], the pJuFo technology 
which uses the pIII-Jun-Fos-cDNA fusion is well 
established for the efficient selection and 
identification of protein-protein interacting partners 
[16]. To determine if these proteins are displayed 
in a native-like conformation, we have generated 
phagemid vectors displaying E. coli PhoA on the 
surface of filamentous phage particles as pIII or 
pVIII fusion proteins via the Jun-Fos linker, 
determined the kinetic parameters of the phagemid-
displayed enzymes and compared them to those of 
soluble PhoA. It has been shown previously that 
functional PhoA can be displayed on the surface of 
filamentous phage [11, 14, 15, 23]. However, only 
McCafferty et al [23] provide detailed kinetic data 
and show that PhoA directly fused to the N-
terminus of pIII exhibits a different Km compared 
to soluble PhoA. 
As shown in Table 1 PhoA displayed on pJuFo –III 
phagemids exhibits a Km of 11.2 µM, which is in 
agreement with published data of soluble PhoA 
[23, 24]. This value is independent from PhoA 
being displayed as pIII or pVIII fusion and 
independent of the IPTG concentration under 
which the nascent PhoA-phagemid is being 
produced.  
 
Table 1. Michaelis constants of different phagemid 
preparations and of soluble PhoA 
Sample c(IPTG) [µM] Km [µM]d) 
pIII-PhoA 0 11.2 (+ 0.1) 
pIII-PhoA 1 12.3 (+ 0.9 ) 
pIII-PhoA 10 9.0 (+ 0.8 ) 
pIII-PhoA 100 9.8 (+ 1.1 ) 
pIII-PhoA 1000 10.1 (+ 1.2 ) 
pVIII-PhoA 0 12.9 (+ 1.0 ) 
pVIII-PhoA 1 12.9 (+ 1.2 ) 
pVIII-PhoA 10 12.3 (+  0.9) 
pVIII-PhoA 100 11.0 (+  0.7) 
pVIII-PhoA 1000 11.0 (+  0.6) 
   
PhoA a)  12.3 (+ 0.2) 
PhoAb)  12.7 
PhoAc)  8.5 
 
a) Km from the present work, b)Km from [24],  c)Km 
from [23]. d)  The standard deviation derived from 
three experiments performed with independent 
freshly prepared phagemids is given in parentheses.  
 
Assuming that the individual rate constants 
composing Km of PhoA-phagemid are comparable 
to those of soluble PhoA the number of active 
enzyme molecules displayed on each phagemid 
particle can be calculated. Figure 2 shows the 
molar activities of wtPhoA, PhoA-pIII-phagemid 
and PhoA-pVIII-phagemid produced in the absence 
of IPTG. Under this condition PhoA is presented 
nearly twice as effectively via pIII than via pVIII. 
However, PhoA-pIII-phagemid shows a molar 
activity of 1587 mol substrate/mol phage/min 
compared to a molar activity of 3539 mol 
substrate/mol enzyme/min for soluble PhoA, 
indicating that only 45% of the phagemids display 
one active enzyme molecule via pIII. 
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Figure 2.  Michaelis-Menten plot of soluble PhoA 
(solid black circles), PhoA-pIII-phagemid (light 
grey squares) and PhoA-pVIII-phagemid (dark 
grey diamonds). Molar activities are plotted against 
the substrate concentration to calculate the kinetic 
parameters summarized in Table 1. 
 
Another aim of this study was to investigate if and 
to what extend addition of IPTG during phagemid 
production would increase the decoration of 
phagemids with active enzyme. We therefore tested 
in a first step the inducibility of the pJuFo::phoA 
vectors by preparing periplasmic fractions from 
phagemid producing XL1-Blue cultures grown 
with or without 1 mM IPTG. The periplasmic 
fractions were then subjected to Western blot 
analysis and the Fos-PhoA fusion protein was 
detected by HRP-labelled anti-bacterial PhoA mAb 
7319. As shown in Figure 3, induction of fos::phoA 
expression is enhanced with IPTG in either of the 
phagemid vectors during the entire period of phage 
propagation. Surprisingly, the difference in 
fos::phoA expression with and without IPTG is 
much less pronounced in pJuFoIII::phoA (Figure 
3A) compared to pJuFoVIII::phoA (Figure 3B). 
This difference might be more obvious if we 
consider that the periplasmic extracts of the 
cultures grown in medium with 1 mM IPTG were 
prepared from a 10 to 15% reduced cell number 
compared to those grown without IPTG (Figure 
3C). 
 
 
 
Figure 3. Western blot analysis of periplasmic 
extracts directly before, ½ h, 1 h, 2 h, 4 h and 10 h 
after helper phage superinfection, and of soluble 
 wtPhoA (left lane). (A) Fos-PhoA detected in 
XL1-Blue harbouring pJuFoIII::phoA without (-) 
and in the presence of 1 mM IPTG (+). (B) Fos-
PhoA detected in XL1-Blue harbouring 
pJuFoVIII::phoA grown without (-) and in the 
presence of 1 mM IPTG (+). (C) Growth rate of 
XL1-blue/pJuFoIII::phoA (squares) and XL1-
blue/pJuFoVIII::phoA (circles) grown without 
(open symbols) and with 1 mM IPTG (solid 
symbols). 
 
To directly investigate the effect of the inducer on 
the valency of PhoA-phagemids we then added 
IPTG to final concentrations of 1 µM, 10 µM, 100 
µM and 1000 µM 30 min after 10 µM, 100 µM and 
1000 µM 30 min after infecting the bacteria with 
helper phage and prepared the phagemids after 
another 9½ h. The molar activities of these PhoA-
phagemids are shown in Figure 4. We observed a 
twofold increase of PhoA-pVIII-phagemid activity 
in the range between 1 µM and 10 µM IPTG with 
an apparent activity saturation at IPTG 
concentrations higher than 10 µM. An increase in 
molar activity could also be detected in the case of 
PhoA-pIII-phagemids at IPTG concentrations ≥ 10 
µM, but it was much less pronounced. Because 
both jun::gIII and fos::phoA are under control of 
lacZ promotors, we consider this behaviour to 
reflect the in vivo dissociation constant of inducer 
and Lac repressor, which is 5.7 µM [25]. 
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Figure 4. Molar activities of soluble dimeric PhoA 
(black), PhoA-pIII-phagemid (light grey) and 
PhoA-pVIII-phagemid (dark grey) in dependence 
on the IPTG concentration. Molar activities of 
PhoA-phagemid are measured per phage particle. 
As control pIII-pJuFo and pVIII-pJuFo phagemids 
without a PhoA fusion were used. The molar 
activities of these control samples were 1.33 and 
1.99 mol substrate converted/mol phage/min 
respectively (small figure top left). 
 
The finding that a maximum of one copy of PhoA 
is displayed on either species of pJuFo phagemids 
could also be confirmed by Western blot analysis 
(Figure 5).  
 
       
 
However, it should be annotated that both total 
phagemid yield as well as their infectivity decrease 
with increasing IPTG concentration as shown in 
Figure 6.  
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Figure 6. Phage yields (solid bars), and 
infectivities (diagonals) of PhoA-pIII-phagemid 
(light grey) and PhoA-pVIII-phagemid (dark grey) 
preparations in the absence and presence of IPTG 
during phage production. 100% represent 4·1013 
phagemids/ml (PhoA-pIII-phagemid) and 9·1013 
phagemids/ml (PhoA-pIII-phagemid) respectively. 
Infectivity is measured in transforming units per 
ml. 
 
The titer of PhoA-pIII-phagemids produced at 
IPTG concentrations ≥ 10 µM was less than 50 % 
compared to the phagemid titers obtained without 
induction, while infectivity decreased almost 
twofold from 1.8 to 1.0 percent. For PhoA-pVIII-
phagemids the total yield even dropped below 30 
% at IPTG concentrations ≥ 10 µM, while 
infectivity decreased from 5.5 (no IPTG) to 3.3 
percent (1000 µM IPTG) and thus was always 
higher compared to the pIII fusion. However, 
infectivity of PhoA-pVIII-phagemids decreased 
significantly after 48 h storage at 4°C, indicating 
that the phage displaying the PhoA-pVIII fusion 
protein is less stable than the phage displaying the 
PhoA-pIII fusion protein (data not shown). 
Therefore we recommend the use of pIII as a 
fusion partner for phage surface display of cDNA 
libraries. 
DISCUSSION   
Success and failure of phage display methods 
critically depend on distinct experimental variables 
and parameters, as was indicated on the basis of 
stochastic models [26]. Besides the effective 
concentration of immobilized high affinity ligands 
and the stringency of washing steps, particularly 
complexity and titer of a phage library as well as 
valency of phage have an impact on the outcoming 
of a biopanning-based selection experiment. In 
order to investigate valency, infectivity and display 
quality of the pJuFo phagemid, which has proven a 
versatile vector for the screening of cDNA libraries 
of various allergic sources [18], human tumor cells 
[19], mice B cells [27], and human fibroblasts [20], 
we generated pJuFo-PhoA phagemids in which 
PhoA was either fused to the minor coat protein 
pIII or to the major coat protein pVIII via a Jun-Fos 
linker. PhoA is a homodimeric protein located in 
the periplasm of E. coli and has a molar mass of 47 
kDa per subunit [28]. There is strong evidence 
from the literature that only dimeric PhoA is 
catalytically active [29, 30]. Therefore, it was 
surprising that the Michaelis constant Km of the 
phage-displayed PhoA was identical to that of 
soluble PhoA (Table 1), indicating that dimeric 
proteins can be displayed in a native-like fashion 
on the surface of pJuFo phagemids and that the two 
intramolecular disulfide bonds present in the PhoA 
subunit are formed correctly. Furthermore, we may 
conclude that the individual rate constants 
composing Km in the PhoA-phagemids are identical 
to those of soluble PhoA. Thus, kcat or molar 
activities of PhoA-phagemids and soluble PhoA 
may be compared directly to calculate the valency 
of PhoA-phagemids. 
As shown in Figure 4 all of the PhoA-phagemid 
populations prepared from incubations with or 
without IPTG display lower activity than the 
soluble PhoA indicating that statistically 
maximally one of the five [31] copies of pIII and 
one of 2700 copies of pVIII represents a PhoA-coat 
protein fusion. This observation is supported by 
Western blot analysis (Figure 5), and thus we may 
conclude that the majority of the displayed PhoA 
fusion molecules are also enzymatically active. 
It has been shown earlier that the decoration of 
filamentous hybrid phage with peptides fused to 
pVIII critically depends on the length of the 
peptide [32-34] and, even more, on the rate of 
processing of the molar pro-coat fusion protein 
[35] which is a critical step in recombinant phage 
assembly. As a result the infectivity of phage 
populations that display a 10 or 16 amino acid 
peptide drops from 20% to 1% [34], respectively. 
Malik et al. [40] have impressively demonstrated 
by Western blot analysis that 12mers and 16mers 
can be displayed in up to 40% and 25% of the 
pVIII copies, respectively. According to their 
model-building approach the phage coat could even 
be decorated with a folded 100 kDa protein at a 
saturation of 24% [35]. However, experiments in 
which the display of a scFv via pIII and pVIII was 
directly compared by ELISA clearly showed that 
pIII was more efficient than pVIII in displaying 
coat fusion proteins even though there are much 
less copies of pIII present in a phage particle [36]. 
Those results generally corroborate our findings 
that the display of PhoA via pIII is more efficient 
than via pVIII when the PhoA-coat protein fusion 
is produced from a phagemid vector in the absence 
of induction (Figure 2). But so far there is no hint 
in the literature why the copy number of displayed 
PhoA should be restricted to one per phage 
particle, even when fused to the major coat protein 
pVIII. 
When produced in the presence of IPTG as strong 
inducer of the lacZ promoter, the titer of PhoA-
pVIII-phagemids was always lower compared to 
PhoA-pIII-phagemids. However, the infectivity of 
the PhoA-pVIII-phagemid remained higher than 
that of the PhoA-pIII-phagemid. 
Taken into account that the complexity of a 
primary cDNA library is usually in the range of 107 
primary clones and that the amplified phagemid 
populations from all experiments exceeded a titer 
of 1·1011 transforming units per ml (tu/ml) it 
remains irrelevant whether the cDNA products are 
displayed via pIII or pVIII. In any case the cDNA 
library will be entirely displayed on the phage 
surface and makes pJuFo an ideal phagemid vector 
for the screening of cDNA libraries from various 
origins.  
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